Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Immediate Effects of Shock Wave Therapy With Stretching or Isometric Contraction on Upper Trapezius (rESWT)

19 mai 2026 mis à jour par: Gukhwa Han, Sahmyook University

The Immediate Effects of Simultaneous Application of Radial Extracorporeal Shock Wave Therapy and Stretching or Isometric Contraction on Muscle Tone, Stiffness, Thickness, Pressure Pain Threshold, and Grip Strength of the Upper Trapezius

Excessive use of smart devices and prolonged sitting posture in modern daily life can lead to potential hypertonicity and functional impairment of the upper trapezius even in healthy individuals. Such conditions may cause functional changes and discomfort before the onset of pain, and early intervention may help prevent the progression to musculoskeletal disorders. Therefore, this study aims to investigate the immediate effects of radial extracorporeal shock wave therapy (rESWT) applied simultaneously with stretching or isometric contraction on muscle tone, stiffness, thickness, pressure pain threshold, and grip strength of the upper trapezius in healthy adults.

Participants will be divided into two groups : rESWT + stretching and rESWT + isometric contraction. Immediate changes in the upper trapezius will be compared before and after the interventions. rESWT will be applied to the upper trapezius with 1.0 bar pressure, 10 Hz frequency, and 1000 shocks.

Aperçu de l'étude

Type d'étude

Interventionnel

Inscription (Réel)

30

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

      • Gwangju, Corée du Sud, 62287
        • 73, Bungmun-daero 419beon-gil, Gwangju health university

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Adulte

Accepte les volontaires sains

Oui

La description

Inclusion Criteria:

  • Individuals with no history of neck or shoulder pain in the past 6 months
  • Individuals with no history of upper limb musculoskeletal disorders
  • Individuals with a pressure pain threshold (PPT) of the upper trapezius ≥ 263 kPa

Exclusion Criteria:

  • Individuals with a history of neurological or orthopedic disorders
  • Individuals taking medications that may affect ESWT response
  • Individuals with local skin conditions, including ulcers or open wounds

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Comparateur actif: experimental 1 group
Radial Extracorporeal Shock Wave Therapy and Stretching

Participants will sit on a chair and receive rESWT with gel applied to the upper trapezius. A 20 mm rESWT applicator angled at 90° will be applied to the muscle belly and the musculotendinous junction. The intensity will be set at 1.0 bar pressure, 10 Hz frequency, with 1000 shocks.

When rESWT is applied to the upper trapezius, participants will sit on a chair and repeatedly bend the neck diagonally to stretch the muscle, then return to the neutral position.

Comparateur actif: experimental 2 group
Radial Extracorporeal Shock Wave Therapy and Isometric Contraction

Participants will sit on a chair and receive rESWT with gel applied to the upper trapezius. A 20 mm rESWT applicator angled at 90° will be applied to the muscle belly and the musculotendinous junction. The intensity will be set at 1.0 bar pressure, 10 Hz frequency, with 1000 shocks.

When rESWT is applied to the upper trapezius, participants will sit on a chair and maintain a shoulder elevation posture during the intervention.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Muscle Tone
Délai: Post-intervention measurement is conducted immediately after the intervention to assess immediate effects.
Upper trapezius muscle stiffness will be assessed as dynamic stiffness (N/m) using the MyotonPRO device (Myoton AS, Tallinn, Estonia). The probe will be positioned perpendicular to the skin over the belly of the upper trapezius muscle. After a pre-load of approximately 0.18 N, 10 mechanical impulses of approximately 0.4 N at 1 Hz will be delivered. Measurements will be repeated 3 times, and the mean value will be used for analysis. Change from baseline will be calculated as the immediate post-intervention value minus the baseline value.
Post-intervention measurement is conducted immediately after the intervention to assess immediate effects.
Muscle Stiffnes
Délai: Post-intervention measurement is conducted immediately after the intervention to assess immediate effects.
Upper trapezius muscle stiffness will be assessed as dynamic stiffness (N/m) using the MyotonPRO device (Myoton AS, Tallinn, Estonia). The probe will be positioned perpendicular to the skin over the belly of the upper trapezius muscle. After a pre-load of approximately 0.18 N, 10 mechanical impulses of approximately 0.4 N at 1 Hz will be delivered. Measurements will be repeated 3 times, and the mean value will be used for analysis. Change from baseline will be calculated as the immediate post-intervention value minus the baseline value.
Post-intervention measurement is conducted immediately after the intervention to assess immediate effects.
Muscle Thickness
Délai: Post-intervention measurement is conducted immediately after the intervention to assess immediate effects.
The probe of the ultrasound imaging device is placed perpendicular to the target area without applying any pressure after applying a water-based transmission gel, in order to measure muscle thickness. Then, using a 2.5 MHz ultrasound, strong echoes at tissue interfaces are focused, and the distance between the focused points is converted into millimeters to determine tissue thickness.
Post-intervention measurement is conducted immediately after the intervention to assess immediate effects.
Grip Strength
Délai: Post-intervention measurement is conducted immediately after the intervention to assess immediate effects.
Grip strength is measured using a wireless dynamometer. The participant holds the dynamometer with the arm relaxed, the elbow flexed at 90°, the arm slightly away from the torso, and the wrist in a neutral position. Following the researcher's instructions, the participant exerts maximum force. The measurement is repeated three times, and the average value is recorded.
Post-intervention measurement is conducted immediately after the intervention to assess immediate effects.
Pressure Pain
Délai: Post-intervention measurement is conducted immediately after the intervention to assess immediate effects.
The participant sits upright with the back supported by a wall or chair and feet flat on the floor. A pressure algometer with a 1 cm² rubber tip is placed perpendicular to the same muscle belly measured by the Myoton PRO. The researcher applies gradual pressure at a constant rate of 0.5 kg/cm²/s until the participant reports pain, and the value at the point of reported pain is recorded. The measurement is repeated twice, and the average value is used.
Post-intervention measurement is conducted immediately after the intervention to assess immediate effects.

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

20 septembre 2025

Achèvement primaire (Réel)

10 octobre 2025

Achèvement de l'étude (Réel)

25 octobre 2025

Dates d'inscription aux études

Première soumission

11 décembre 2025

Première soumission répondant aux critères de contrôle qualité

19 mai 2026

Première publication (Réel)

27 mai 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

27 mai 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

19 mai 2026

Dernière vérification

1 mai 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner